Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
Submitted by
admin
on September 7, 2017 - 9:35am
Source:
Stat
News Tags:
Alzheimer's disease
Axovant
David Hung
dimebon
Medivation
intepirdine
Headline:
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
Do Not Allow Advertisers to Use My Personal information
